Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
12.82
+0.18 (1.42%)
At close: Oct 15, 2026, 4:00 PM EDT
12.85
+0.03 (0.23%)
After-hours: Oct 15, 2026, 7:59 PM EDT
Novavax Employees
Novavax had 749 employees as of December 31, 2025. The number of employees decreased by 203 or -21.32% compared to the previous year. That makes Novavax the 16,973rd largest employer in the world and 2,381st in the United States.
Employees
749
Change (1Y)
-203
Growth (1Y)
-21.32%
Revenue / Employee
$552,465
Profits / Employee
-$330,748
Market Cap
2.11B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Recursion Pharmaceuticals | 600 |
| Vericel | 398 |
| Harmony Biosciences Holdings | 293 |
| Viridian Therapeutics | 252 |
| Immunome | 247 |
| Celldex Therapeutics | 198 |
| Disc Medicine | 165 |
NVAX News
- 18 hours ago - Novavax price target raised to $8 from $7 at Citi - TheFly
- 6 days ago - Novavax price target raised to $8 from $7 at BofA - TheFly
- 9 days ago - Novavax Stock (NVAX) Plunges After WHO Calms Plague Fears - TipRanks
- 5 weeks ago - Novavax Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 5 weeks ago - Novavax Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 6 weeks ago - Novavax to Participate in September Investor Conferences - PRNewsWire
- 6 weeks ago - Novavax’s partners approved for Nuvaxovid formulation for vaccination season - TheFly
- 6 weeks ago - Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season - PRNewsWire